Iran And NotJasmin Wagner
List of bibliographic references
Number of relevant bibliographic references: 22.Ident. | Authors (with country if any) | Title |
---|---|---|
000041 | Hadir Shakshouk [États-Unis, Égypte] ; Maryam Daneshpazhooh [Iran] ; Dedee F. Murrell [Australie] ; Julia S. Lehman [États-Unis] | Treatment considerations for patients with pemphigus during the COVID-19 pandemic |
000059 | Banafsheh Mosharmovahed [Iran] ; Yousef Fatahi [Iran] ; Bahareh Mohebbi [Iran] ; Sohrab Ali Ghorbanian [Iran] ; Sara Assadiasl [Iran] | Tocilizumab in transplantation. |
000106 | Akram Aminjafari [Iran] ; Sorayya Ghasemi [Iran] | The Possible of Immunotherapy for COVID-19: a Systematic Review |
000216 | Elaheh Kordzadeh-Kermani [Iran] ; Hossein Khalili [Iran] ; Iman Karimzadeh [Iran] ; Mohammadreza Salehi [Iran] | Prevention Strategies to Minimize the Infection Risk Associated with Biologic and Targeted Immunomodulators |
000225 | Ali Rismanbaf [Iran] | Potential Treatments for COVID-19; a Narrative Literature Review |
000334 | Amin Gasmi [France] ; Sadaf Noor [Pakistan] ; Torsak Tippairote [Thaïlande] ; Maryam Dadar [Iran] ; Alain Menzel [France] ; Geir Bj Rklund [Norvège] | Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic |
000395 | Mohsen Jari [Iran] ; Reza Shiari [Iran] ; Omid Salehpour [Iran] ; Khosro Rahmani [Iran] | Epidemiological and advanced therapeutic approaches to treatment of uveitis in pediatric rheumatic diseases: a systematic review and meta-analysis |
000475 | Farzaneh Dastan [Iran] ; Ali Saffaei [Iran] ; Seyed Mehdi Mortazavi [Iran] ; Hamidreza Jamaati [Iran] ; Nadia Adnani [Iran] ; Sasan Samiee Roudi [Iran] ; Arda Kiani [Iran] ; Atefeh Abedini [Iran] ; Seyed Mohammadreza Hashemian [Iran] | Continues Renal Replacement Therapy (CRRT) With Disposable Hemoperfusion Cartridge: A Promising Option for Severe COVID-19 |
000565 | Ali Aminian [États-Unis] ; Mohammad Kermansaravi [Iran] ; Shahriar Azizi [Iran] ; Peyman Alibeigi [Iran] ; Sina Safamanesh [Iran] ; Ali Mousavimaleki [Iran] ; Mohammad Taghi Rezaei [Iran] ; Maziar Faridi [Iran] ; Somayeh Mokhber [Iran] ; Abdolreza Pazouki [Iran] ; Saeed Safari [Iran] | Bariatric Surgical Practice During the Initial Phase of COVID-19 Outbreak |
000948 | Fatemeh Sanie-Jahromi [Iran] ; Masoomeh Eghtedari [Iran] ; Esmaeil Mirzaei [Iran] ; Mohammad Hassan Jalalpour [Iran] ; Zahra Asvar [Iran] ; Mahmood Nejabat [Iran] ; Fahimeh Javidi-Azad [Iran] | Propagation of limbal stem cells on polycaprolactone and polycaprolactone/gelatin fibrous scaffolds and transplantation in animal model |
000C05 | Xiaoying Sun [République populaire de Chine] ; Raheleh Roudi [Iran] ; Ting Dai [République populaire de Chine] ; Shangya Chen ; Bin Fan [République populaire de Chine] ; Hongjin Li [République populaire de Chine] ; Yaqiong Zhou [République populaire de Chine] ; Min Zhou [République populaire de Chine] ; Bo Zhu [États-Unis] ; Chengqian Yin [États-Unis] ; Bin Li [République populaire de Chine] ; Xin Li [République populaire de Chine] | Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA systematic review and meta-analysis |
000C21 | Hassan Yousefi [Iran] ; Majid Momeny [Iran] ; Seyed H. Ghaffari [Iran] ; Nazanin Parsanejad [Iran] ; Arash Poursheikhani [Iran] ; Sepehr Javadikooshesh [Iran] ; Ghazaleh Zarrinrad [Iran] ; Fatemeh Esmaeili [Iran] ; Zivar Alishahi [Iran] ; Zahra Sabourinejad [Iran] ; Ghazaleh Sankanian [Iran] ; Sahar Shamsaiegahkani [Iran] ; Davood Bashash [Iran] ; Narjes Shahsavani [Canada] ; Javad Tavakkoly-Bazzaz [Iran] ; Kamran Alimoghaddam [Iran] ; Ardeshir Ghavamzadeh [Iran] | IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer. |
001775 | Forouhe Zahir-Jouzdani [Iran] ; Fatemeh Atyabi [Iran] ; Nazanin Mojtabavi | Interleukin-6 participation in pathology of ocular diseases. |
001817 | Arman Ahmadzadeh [Iran] ; Alireza N. Farahmand [Iran] ; Latif Gachkar [Iran] | Evaluation of safety, efficacy and post-cessation efficacy durability of tocilizumab in patients with active rheumatoid arthritis. |
001C14 | Amir Hashemi-Meshkini [Iran] ; Shekoufeh Nikfar [Iran] ; Elizabeth Glaser [États-Unis] ; Ahmadreza Jamshidi [Iran] ; Seyed Alireza Hosseini [Iran] | Cost-Effectiveness Analysis of Tocilizumab in Comparison with Infliximab in Iranian Rheumatoid Arthritis Patients with Inadequate Response to tDMARDs: A Multistage Markov Model. |
001F10 | Mohammed Hammoudeh [Qatar] ; Adel Al Awadhi [Koweït] ; Eman Haji Hasan [Koweït] ; Maassoumeh Akhlaghi [Iran] ; Arman Ahmadzadeh [Iran] ; Bahar Sadeghi Abdollahi [Iran] | Safety, Tolerability, and Efficacy of Tocilizumab in Rheumatoid Arthritis: An Open-Label Phase 4 Study in Patients from the Middle East. |
002125 | Haydarali Esmaili [Iran] ; Elmira Mostafidi [Iran] ; Bahareh Mehramuz [Iran] ; Mohammadreza Ardalan [Iran] ; Mohammadali Mohajel-Shoja [États-Unis] | An update on renal involvement in hemophagocytic syndrome (macrophage activation syndrome) |
002546 | Gholamreza Azizi [Iran] ; Roobina Boghozian [Iran] ; Abbas Mirshafiey [Iran] | The potential role of angiogenic factors in rheumatoid arthritis |
002787 | Seema Kalra [Royaume-Uni] ; Alan Silman [Royaume-Uni] ; Gulsen Akman-Demir [Turquie] ; Saeed Bohlega [Arabie saoudite] ; Afshin Borhani-Haghighi [Iran] ; Cris S. Constantinescu [Royaume-Uni] ; Habib Houman [Tunisie] ; Alfred Mahr [France] ; Carlos Salvarani [Italie] ; Petros P. Sfikakis [Grèce] ; Aksel Siva [Turquie] ; Adnan Al-Araji [Royaume-Uni] | Diagnosis and management of Neuro-Behçet’s disease: international consensus recommendations |
003A53 | Kamal Esalatmanesh [Iran] ; Raika Jamali [Iran] ; Arsia Jamali [Iran] ; Bardia Jamali [Iran] ; Mohammadreza Nikbakht [Iran] | Serum anti-cyclic citrullinated peptide antibodies may predict disease activity in rheumatoid arthritis |
003A54 | Batool Zamani [Iran] ; Raika Jamali [Iran] ; Arsia Jamali [Iran] | Serum adenosine deaminase may predict disease activity in rheumatoid arthritis |
003D52 | Afshin Borhani Haghighi [Iran] ; Anahid Safari [Iran] | Proposing an algorithm for treatment of different manifestations of neuro-Behcet’s disease |
This area was generated with Dilib version V0.6.34. |